BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18324350)

  • 1. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.
    Oshima S; Kawamura O
    Clin Exp Nephrol; 2008 Aug; 12(4):264-269. PubMed ID: 18324350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
    Harmankaya O; Oztürk Y; Baştürk T; Obek A; Kiliçarslan I
    Int Urol Nephrol; 2002; 33(1):167-71. PubMed ID: 12090325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
    Ballardie FW; Roberts ISD
    J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
    Chen KJ; Cheng CH; Wu MJ; Chen CH; Shu KH
    J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
    J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis.
    Beck N; Walz G; Schneider J
    Kidney360; 2022 Mar; 3(3):506-515. PubMed ID: 35582170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.
    Rasche FM; Keller F; Rasche WG; Schiekofer S; Kahn T; Fahnert J
    Clin Exp Immunol; 2016 Feb; 183(2):307-16. PubMed ID: 26439797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
    Mitsuiki K; Harada A; Okura T; Higaki J
    Clin Exp Nephrol; 2007 Dec; 11(4):297-303. PubMed ID: 18085391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A typical Wegeners granulomatosis -- but not pauci-immune!
    Joerg L; Kerstin A; Niko B; Dominik A; Martin K; Latus J; Amann K; Braun N; Alscher MD; Kimmel M
    Minerva Urol Nefrol; 2012 Jun; 64(2):149-52. PubMed ID: 22617309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
    Ihm HS; Lee JY; Hwang HS; Kim YG; Moon JY; Lee SH; Jeong KH; Lee TW; Ihm CG
    Clin Nephrol; 2019 Sep; 92(3):131-140. PubMed ID: 31232271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC; Lee TW; Kim MJ; Yang MH; Ihm CG
    Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
    ; Jiang XY
    Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA; Lohavichan V; Hennigar R
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.